MB Clinical Academy Releases its First Two Educational Programs
MB Clinical Academy produces educational materials to help clinicians, clinical research professionals and students more effectively manage the cardiometabolic health of their patients/clients, and to understand the strengths and limitations of the available evidence, including gaps that can be filled with future studies.
We have just completed two new programs, which will be available for purchase and download during the week of July 10, 2017.
Diet and Prevention of Type 2 Diabetes Mellitus: Beyond Weight Loss and Exercise
This short course will review the evidence for dietary factors in the prevention of type 2 diabetes mellitus (T2D). It contains three modules that will cover:
- Module 1: Epidemiology and pathophysiology of T2D
- Module 2: Predictors of T2D risk and effects of interventions on incidence
- Module 3: Summary of the associations and mechanisms through which diet may affect T2D risk, with an emphasis on insulin sensitivity and glycemic load
Interpreting Efficacy Results from Cardiovascular Outcomes Trials
Cardiovascular outcomes trials are integral to evidence-based medicine, and they are the most effective means for demonstrating that an intervention reduces major adverse cardiovascular events. A sound understanding of the fundamentals of clinical study design and statistical methodology is essential for the interpretation of efficacy results from cardiovascular outcomes trials. However, most clinicians have not had extensive training on how to interpret measures of association and statistical procedures used to assess the efficacy of interventions intended to reduce cardiovascular event risk. This course will review of the following concepts and their use in cardiovascular outcomes studies:
- Measures of cardiovascular event incidence
- Relative risk
- Hazard ratio
- Odds ratio
- Comparing event rates and treatment effects
- Relative risk reduction
- Absolute risk reduction
- Number needed to treat (or harm)
- Pitfalls when making comparisons between cardiovascular outcomes trials, including the three most important questions
- Who was studied (risk profile)?
- What outcomes were assessed?
- Over what time period?
- Additional factors to consider in the interpretation of findings from cardiovascular outcomes trials
- Evaluating the roles of chance, bias and confounding
- Factors affecting validity and generalizability
- Assessing the potential for type I and type II statistical errors
We expect that those who purchase these programs will find them informative and practical. If you have suggestions for future programs, don’t hesitate to send us an email: firstname.lastname@example.org.